Rebekah Jordan talks with Peter Shone, chief technology officer, iethico, about its latest AI-powered platform that can give clear indications of medicine shortages and predict future supply chain challenges - and what this means for pharmacists.
EPM held a Q&A session with Vincent Rolland, Idorsia Pharmaceuticals, and Richard Young, Veeva, to discuss how investing in digital data management can benefit biopharma, from clinical trials through to market.
Kari Miller, sr. director, Product Management, SmartSolve, IQVIA explores why purpose-built QMS technology is necessary for the life science industry, from mitigating risk to maintaining regulatory compliance.
Tali Harif, Ph.D, MBA, director, Business Development, UK & Europe at 374Water, shares how pharma manufacturers can adopt responsible waste management, and contribute to a cleaner, safer environment for employees and the community.
Jon Sewell, special projects manager (Aseptic Filling Program Lead), Origin, looks at the rise of cleanrooms-on-demand in the pharma manufacturing sector, the challenges it helps to overcome and whether this could become the future blueprint.
Allison Hoffman, global product manager, Cell Therapy Technologies, Terumo BCT, discusses how automation is leading the way to optimising autologous manufacturing in the C> sector.
Rebekah Jordan sat down with Lynn Durham, CEO & founder of STALICLA, to discuss STALICLA’s recent partnership with Evgen Pharma that aims bring a therapeutic option to currently underserved patients with neurodevelopmental disorders (NDDs).
EPM chats with Pratima Cherukuri, chief scientific officer, Genezen, who shares the considerations in the development and manufacture of lentiviral vectors, and highlights some of the challenges organisations may face along the way.
Here Dr. Carmen Guguta, global head of business development and marketing at crystallisation technology provider Technobis Crystallization Systems, explains how new technology is streamlining crystallisation research.
Ahead of World Stroke Day, David Budd, CEO of genedrive plc, underscores the growing role of pharmacogenetics in personalised medicine and how its application can decrease the odds of secondary cerebrovascular disease.
Marco Pelka, market manager PCE of Mettler-Toledo, explains how manufacturers and packaging companies in this field can harness product inspection to ensure they produce high quality liquid pharmaceutical products.
Luigi Boltri, PH.D., senior director, Pharmaceutical Sciences, Adare Pharma Solutions, addresses the challenges of paediatric formulations, and how specialised technology platforms can provide ease of application and improve patient outcomes.
